Accepted for/Published in: JMIR Public Health and Surveillance
Date Submitted: Jul 29, 2023
Open Peer Review Period: Jul 29, 2023 - Dec 29, 2023
Date Accepted: Dec 29, 2023
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
“Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients with Hemophilia A in China: Discrete Choice Experiment Study”: comments from Huang et al.
ABSTRACT
With great interest, we read about the paper by Wang et al. which described a discrete choice experiment among adult patients with hemophilia A in China. The results are not surprising and in accordance with clinical routine.[1] It provides valuable insights into the preferences of patients as for prophylaxis in hemophilia A. In this research, the annual bleeding rate was assigned as an important item in the questionnaire. This is rational as most clinical studies (in hemophilia) take it as main clinical outcome. However, the annual bleeding rate should be more specific for the at least joint bleeding and spontaneous bleeding.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.